Fulgent Genetics, Inc.
FLGT- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001674930
In the last 90 days, Fulgent Genetics, Inc. insiders filed 0 open-market purchases and 4 sales; 141 institutions reported holding it in 13F filings for Q2 2026, worth $321.8M in total; no superinvestor holds it.
Holders of 5% or more of FLGT
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Fulgent Genetics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Hsieh Ming | 13D/A | 32.26%8.87M shares | +1.52 ppfrom 30.74% | Mar 31, 20262 filings | May 27, 2026 | SEC |
| Barclays PLC | 13G/A | 7.57%2.34M shares | +2.15 ppfrom 5.42% | Feb 7, 20253 filings | May 13, 2025 | SEC |
| BlackRock, Inc. | 13G/A | 5.90%1.82M shares | – | Apr 3, 20251 filing | Apr 3, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
11 Schedule 13D and 13G filings on Fulgent Genetics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| May 27, 20267:42 PM ET | Hsieh Mingand 1 other | 13D/A | 32.26%8.87M shares | +1.52 ppfrom 30.74% | May 22, 2026 | SEC |
| Mar 31, 20264:55 PM ET | Hsieh Mingand 1 other | 13D/A | 30.74%8.87M shares | – | Mar 19, 2026 | SEC |
| Feb 4, 20265:05 PM ET | Millennium Management LLCand 3 others | 13G/A | 3.00%939.4K shares | −2.60 ppfrom 5.60%Below 5% | Dec 31, 2025 | SEC |
| Jul 29, 20255:04 PM ET | Millennium Management LLCand 3 others | 13G/A | 5.60%1.69M shares | +0.90 ppfrom 4.70% | Jul 22, 2025 | SEC |
| Jul 29, 20254:23 PM ET | Millennium Management LLCand 2 others | 13G/A | 4.70%1.44M shares | −1.80 ppfrom 6.50%Below 5% | Jun 30, 2025 | SEC |
| May 13, 20254:30 PM ET | Barclays PLC | 13G/A | 7.57%2.34M shares | +2.15 ppfrom 5.42% | Mar 31, 2025 | SEC |
| May 6, 20254:04 PM ET | Millennium Management LLCand 2 others | 13G/A | 6.50%1.97M shares | +1.50 ppfrom 5.00% | Mar 31, 2025 | SEC |
| Apr 3, 20254:17 PM ET | BlackRock, Inc. | 13G/A | 5.90%1.82M shares | – | Mar 31, 2025 | SEC |
| Mar 21, 20254:52 PM ET | Barclays PLC | 13G/A | 5.42%1.66M shares | 0.00 ppfrom 5.42% | Dec 31, 2024 | SEC |
| Feb 7, 20254:34 PM ET | Barclays PLC | 13G | 5.42%1.66M shares | New | Dec 31, 2024 | SEC |
| Jan 8, 20254:00 PM ET | Millennium Management LLCand 2 others | 13G | 5.00%1.53M shares | New | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Fulgent Genetics, Inc. shares.
No Form 144 notices for Fulgent Genetics, Inc. are on file.